Institutions / Kynam Capital Management, LP
Kynam Capital Management, LP
CIK 1907884 · Institution · as of Dec 31, 2025
Portfolio value
$1.54B
Positions
35
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 35 →
| Company | Value | % of portfolio |
|---|---|---|
| Cogent Biosciences, Inc. | $218.99M | 14.3% |
| Vera Therapeutics, Inc. | $173.85M | 11.3% |
| Syndax Pharmaceuticals Inc | $169.15M | 11.0% |
| Celldex Therapeutics, Inc. | $161.42M | 10.5% |
| Vaxcyte, Inc. | $134.84M | 8.8% |
| Biocryst Pharmaceuticals Inc | $73.06M | 4.8% |
| Beam Therapeutics Inc. | $67.64M | 4.4% |
| Viridian Therapeutics, Inc. | $45.76M | 3.0% |
| Tyra Biosciences, Inc. | $41.13M | 2.7% |
| CG Oncology, Inc. | $39.27M | 2.6% |
| CytomX Therapeutics, Inc. | $38.20M | 2.5% |
| Nurix Therapeutics, Inc. | $37.38M | 2.4% |
| Wave Life Sciences Ltd | $36.87M | 2.4% |
| Cullinan Therapeutics, Inc. | $32.23M | 2.1% |
| Immunocore Holdings Plc-AdrIMCR | $29.73M | 1.9% |
| MBX Biosciences, Inc.MBX | $29.48M | 1.9% |
| KalVista Pharmaceuticals Inc | $29.25M | 1.9% |
| Apellis Pharmaceuticals, Inc. | $22.82M | 1.5% |
| Dynavax Technologies Corp | $21.16M | 1.4% |
| Burning Rock Biotech LtdBNR | $20.05M | 1.3% |
| Travere Therapeutics, Inc. | $19.79M | 1.3% |
| Pharvaris N.V. | $17.77M | 1.2% |
| enGene Therapeutics Inc. | $13.48M | 0.9% |
| Relay Therapeutics, Inc. | $12.05M | 0.8% |
| Biohaven Ltd. | $7.94M | 0.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.